Affiliation:
1. Faculty of Pharmaceutical Sciences, Hokkaido University
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Reference12 articles.
1. 1) GuhaSarkar S, Banerjee R. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies. J. Control. Release, 148, 147–159 (2010).
2. 2) Liu HT, Chen SH, Chancellor MB, Kuo HC. Presence of cleaved synaptosomal-associated protein-25 and decrease of purinergic receptors P2X3 in the bladder urothelium influence efficacy of botulinum toxin treatment for overactive bladder syndrome. PLoS ONE, 10, e0134803 (2015).
3. 3) Chuang YC, Kaufmann JH, Chancellor DD, Chancellor MB, Kuo HC. Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial. J. Urol., 192, 1743–1749 (2014).
4. 4) Lander EB, See JR. Intravesical instillation of pentosan polysulfate encapsulated in a liposome nanocarrier for interstitial cystitis. Am J Clin Exp Urol, 2, 145–148 (2014).
5. 5) Nirmal J, Tyagi P, Chancellor MB, Kaufman J, Anthony M, Chancellor DD, Chen YT, Chuang YC. Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure. J. Urol., 189, 1553–1558 (2013).
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献